Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.05 USD | +1.01% | +1.40% | +14.96% |
Mar. 14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
Mar. 13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.96% | 378M | |
-2.86% | 87.37B | |
+3.95% | 41.01B | |
-22.18% | 28.08B | |
+53.11% | 24.72B | |
-5.37% | 17.47B | |
-44.23% | 11.69B | |
-18.06% | 11.6B | |
-13.96% | 11.56B | |
-0.22% | 8.44B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 Revenue $36.7M, vs. Street Est of $32.9M